The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Artemisinin Action and Resistance in Plasmodium falciparum
Open accessAbstract
The worldwide use of artemisinin-based combination therapies (ACTs) has contributed in recent years to a substantial reduction in deaths resulting from Plasmodium falciparum malaria. Resistance to artemisinins, however, has emerged in Southeast Asia. Clinically, resistance is defined as a slower rate of parasite clearance in patients treated with an artemisinin derivative or an ACT. These slow clearance rates associate with enhanced survival rates of ring-stage parasites briefly exposed in vitro to dihydroartemisinin. We describe recent progress made in defining the molecular basis of artemisinin resistance, which has identified a primary role for the P. falciparum K13 protein. Using K13 mutations as molecular markers, epidemiological studies are now tracking the emergence and spread of artemisinin resistance. Mechanistic studies suggest potential ways to overcome resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signal integration in the endoplasmic reticulum unfolded protein response
Ron, D., & Walter, P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2199 · Cited by 6,296
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090
A proteomic view of the Plasmodium falciparum life cycle
Florens, L., Washburn, M. P., Raine, J. D., Anthony, R. M., Grainger, M., Haynes, J. D., Moch, J. K., Muster, N., Sacci, J. B., Tabb, D. L., et al. (2002) · Nature · doi:10.1038/nature01107 · Cited by 1,308
Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival
Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J., & Diehl, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7198-7209.2003 · Cited by 1,234
White, N. J., Pukrittayakamee, S., Hien, T. T., Faiz, M. A., Mokuolu, O. A., & Dondorp, A. M. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60024-0 · Cited by 1,123
Artemisinins target the SERCA of Plasmodium falciparum
Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., O'Neill, P. M., Bray, P. G., Ward, S. A., & Krishna, S. (2003) · Nature · doi:10.1038/nature01813 · Cited by 1,027
Qinghaosu (Artemisinin): The Price of Success
White, N. J. (2008) · Science · doi:10.1126/science.1155165 · Cited by 954
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Phyo, A. P., Nkhoma, S., Stepniewska, K., Ashley, E. A., Nair, S., McGready, R., ler Moo, C., Al-Saai, S., Dondorp, A. M., Lwin, K. M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60484-x · Cited by 924
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
Price, R. N., Uhlemann, A.-C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., Patel, R., Laing, K., Looareesuwan, S., White, N. J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16767-6 · Cited by 853
The POZ domain: a conserved protein-protein interaction motif.
Bardwell, V. J., & Treisman, R. (1994) · Genes & Development · doi:10.1101/gad.8.14.1664 · Cited by 751
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Straimer, J., Gnädig, N. F., Witkowski, B., Amaratunga, C., Duru, V., Ramadani, A. P., Dacheux, M., Khim, N., Zhang, L., Lam, S., et al. (2015) · Science · doi:10.1126/science.1260867 · Cited by 728
Self-citationArtemisinin: mechanisms of action, resistance and toxicity
Meshnick, S. R. (2002) · International Journal for Parasitology · doi:10.1016/s0020-7519(02)00194-7 · Cited by 720
Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations
Sidhu, A. B. S., Verdier-Pinard, D., & Fidock, D. A. (2002) · Science · doi:10.1126/science.1074045 · Cited by 720
Self-citationSequence and structural analysis of BTB domain proteins
Stogios, P. J., Downs, G. S., Jauhal, J. J., Nandra, S. K., & Privé, G. G. (2005) · Genome Biology · doi:10.1186/gb-2005-6-10-r82 · Cited by 694 · cited 2×
“BTB/POZ/BACK domains can be involved in binding to cullin 3, the largest family of E3 ubiquitin ligases [99], with the downstream Kelch domain providing a substrate adaptor [100].”
Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system
Ghorbal, M., Gorman, M., Macpherson, C. R., Martins, R. M., Scherf, A., & Lopez-Rubio, J.-J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2925 · Cited by 653
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
Wang, J., Zhang, C.-J., Chia, W. N., Loh, C. C. Y., Li, Z., Lee, Y. M., He, Y., Yuan, L.-X., Lim, T. K., Liu, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10111 · Cited by 633
Witkowski, B., Amaratunga, C., Khim, N., Sreng, S., Chim, P., Kim, S., Lim, P., Mao, S., Sopha, C., Sam, B., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70252-4 · Cited by 629
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Genetic architecture of artemisinin-resistant Plasmodium falciparum
Miotto, O., Amato, R., Ashley, E. A., MacInnis, B., Almagro-Garcia, J., Amaratunga, C., Lim, P., Mead, D., Oyola, S. O., Dhorda, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3189 · Cited by 609
The kelch repeat superfamily of proteins: propellers of cell function
Adams, J., Kelso, R., & Cooley, L. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01673-6 · Cited by 600
A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria
Mbengue, A., Bhattacharjee, S., Pandharkar, T., Liu, H., Estiu, G., Stahelin, R. V., Rizk, S. S., Njimoh, D. L., Ryan, Y., Chotivanich, K., et al. (2015) · Nature · doi:10.1038/nature14412 · Cited by 597
The Molecular Mechanism of Action of Artemisinin—The Debate Continues
O’Neill, P. M., Barton, V. E., & Ward, S. A. (2010) · Molecules · doi:10.3390/molecules15031705 · Cited by 595
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
Eastman, R. T., & Fidock, D. A. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2239 · Cited by 568
Self-citationA Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
Ménard, D., Khim, N., Beghain, J., Adegnika, A. A., Shafiul-Alam, M., Amodu, O., Rahim-Awab, G., Barnadas, C., Berry, A., Boum, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513137 · Cited by 551
Self-citationA Medicinal Chemistry Perspective on Artemisinin and Related Endoperoxides
O'Neill, P. M., & Posner, G. H. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030571c · Cited by 538
Amm, I., Sommer, T., & Wolf, D. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.031 · Cited by 493
Amaratunga, C., Lim, P., Suon, S., Sreng, S., Mao, S., Sopha, C., Sam, B., Dek, D., Try, V., Amato, R., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00487-9 · Cited by 493
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia
Miotto, O., Almagro-Garcia, J., Manske, M., MacInnis, B., Campino, S., Rockett, K. A., Amaratunga, C., Lim, P., Suon, S., Sreng, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2624 · Cited by 462
Targeting of protein ubiquitination by BTB–Cullin 3–Roc1 ubiquitin ligases
Furukawa, M., He, Y. J., Borchers, C., & Xiong, Y. (2003) · Nature Cell Biology · doi:10.1038/ncb1056 · Cited by 458
Mok, S., Ashley, E. A., Ferreira, P. E., Zhu, L., Lin, Z., Yeo, T., Chotivanich, K., Imwong, M., Pukrittayakamee, S., Dhorda, M., et al. (2015) · Science · doi:10.1126/science.1260403 · Cited by 435
Malaria medicines: a glass half full?
Wells, T. N. C., van Huijsduijnen, R. H., & Van Voorhis, W. C. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4573 · Cited by 430
Sidhu, A. B. S., Uhlemann, A., Valderramos, S. G., Valderramos, J., Krishna, S., & Fidock, D. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/507115 · Cited by 415
Self-citationTreeck, M., Sanders, J. L., Elias, J. E., & Boothroyd, J. C. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.09.004 · Cited by 390
A Major Genome Region Underlying Artemisinin Resistance in Malaria
Cheeseman, I. H., Miller, B. A., Nair, S., Nkhoma, S., Tan, A., Tan, J. C., Al Saai, S., Phyo, A. P., Moo, C. L., Lwin, K. M., et al. (2012) · Science · doi:10.1126/science.1215966 · Cited by 381
Charman, S. A., Arbe-Barnes, S., Bathurst, I. C., Brun, R., Campbell, M., Charman, W. N., Chiu, F. C. K., Chollet, J., Craft, J. C., Creek, D. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015762108 · Cited by 373
Amaratunga, C., Sreng, S., Suon, S., Phelps, E. S., Stepniewska, K., Lim, P., Zhou, C., Mao, S., Anderson, J. M., Lindegardh, N., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70181-0 · Cited by 344
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Meister, S., Plouffe, D. M., Kuhen, K. L., Bonamy, G. M. C., Wu, T., Barnes, S. W., Bopp, S. E., Borboa, R., Bright, A. T., Che, J., et al. (2011) · Science · doi:10.1126/science.1211936 · Cited by 338
Self-citationVeiga, M. I., Dhingra, S. K., Henrich, P. P., Straimer, J., Gnädig, N., Uhlemann, A.-C., Martin, R. E., Lehane, A. M., & Fidock, D. A. (2016) · Nature Communications · doi:10.1038/ncomms11553 · Cited by 335
Self-citationArtemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion
Klonis, N., Crespo-Ortiz, M. P., Bottova, I., Abu-Bakar, N., Kenny, S., Rosenthal, P. J., & Tilley, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104063108 · Cited by 333
Self-citationTargeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance
Dogovski, C., Xie, S. C., Burgio, G., Bridgford, J., Mok, S., McCaw, J. M., Chotivanich, K., Kenny, S., Gnädig, N., Straimer, J., et al. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002132 · Cited by 327
Self-citationIncreased Tolerance to Artemisinin in Plasmodium falciparum Is Mediated by a Quiescence Mechanism
Witkowski, B., Lelièvre, J., López Barragán, M. J., Laurent, V., Su, X.-Z., Berry, A., & Benoit-Vical, F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01636-09 · Cited by 317
Adjalley, S. H., Johnston, G. L., Li, T., Eastman, R. T., Ekland, E. H., Eappen, A. G., Richman, A., Sim, B. K. L., Lee, M. C. S., Hoffman, S. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112037108 · Cited by 309
Self-citationReduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia
Witkowski, B., Khim, N., Chim, P., Kim, S., Ke, S., Kloeung, N., Chy, S., Duong, S., Leang, R., Ringwald, P., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01868-12 · Cited by 308
Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action
Meshnick, S. R., Thomas, A., Ranz, A., Xu, C.-M., & Pan, H.-Z. (1991) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(91)90062-b · Cited by 303
Leang, R., Taylor, W. R. J., Bouth, D. M., Song, L., Tarning, J., Char, M. C., Kim, S., Witkowski, B., Duru, V., Domergue, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00835-15 · Cited by 302
Genomic epidemiology of artemisinin resistant malaria
MalariaGEN Plasmodium falciparum Community Project (2016) · eLife · doi:10.7554/elife.08714 · Cited by 297
Drug‐resistant malaria: Molecular mechanisms and implications for public health
Petersen, I., Eastman, R., & Lanzer, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.042 · Cited by 289
Ginsburg, H., Famin, O., Zhang, J., & Krugliak, M. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00184-1 · Cited by 287
Venkatesan, M., Gadalla, N. B., Stepniewska, K., Dahal, P., Nsanzabana, C., Moriera, C., Price, R. N., Mårtensson, A., Rosenthal, P. J., Dorsey, G., et al. (2014) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0031 · Cited by 285
Taylor, S. M., Parobek, C. M., DeConti, D. K., Kayentao, K., Coulibaly, S. O., Greenwood, B. M., Tagbor, H., Williams, J., Bojang, K., Njie, F., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu467 · Cited by 283
Loria, P. M., Miller, S. K., Foley, M., & Tilley, L. M. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3390363 · Cited by 272
Self-citationSilvestrini, F., Lasonder, E., Olivieri, A., Camarda, G., van Schaijk, B., Sanchez, M., Younis Younis, S., Sauerwein, R., & Alano, P. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900479-mcp200 · Cited by 272
Takala-Harrison, S., Clark, T. G., Jacob, C. G., Cummings, M. P., Miotto, O., Dondorp, A. M., Fukuda, M. M., Nosten, F., Noedl, H., Imwong, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211205110 · Cited by 266
Ismail, H. M., Barton, V., Phanchana, M., Charoensutthivarakul, S., Wong, M. H. L., Hemingway, J., Biagini, G. A., O’Neill, P. M., & Ward, S. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600459113 · Cited by 261
Update on the Kelch-like (KLHL) gene family
Dhanoa, B. S., Cogliati, T., Satish, A. G., Bruford, E. A., & Friedman, J. S. (2013) · Human Genomics · doi:10.1186/1479-7364-7-13 · Cited by 258
Artemisinin Directly Targets Malarial Mitochondria through Its Specific Mitochondrial Activation
Wang, J., Huang, L., Li, J., Fan, Q., Long, Y., Li, Y., & Zhou, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009582 · Cited by 256
Born to bind: the BTB protein–protein interaction domain
Perez‐Torrado, R., Yamada, D., & Defossez, P. (2006) · BioEssays · doi:10.1002/bies.20500 · Cited by 253
Insights into the Role of Heme in the Mechanism of Action of Antimalarials
Combrinck, J. M., Mabotha, T. E., Ncokazi, K. K., Ambele, M. A., Taylor, D., Smith, P. J., Hoppe, H. C., & Egan, T. J. (2013) · ACS Chemical Biology · doi:10.1021/cb300454t · Cited by 251
Spring, M. D., Lin, J. T., Manning, J. E., Vanachayangkul, P., Somethy, S., Bun, R., Se, Y., Chann, S., Ittiverakul, M., Sia-ngam, P., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70049-6 · Cited by 244
Artemisinins: mechanisms of action and potential for resistance
KRISHNA, S., UHLEMANN, A., & HAYNES, R. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.07.001 · Cited by 243
Pandey, A. V., Tekwani, B. L., Singh, R. L., & Chauhan, V. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19383 · Cited by 241
Structure- and function-based design of Plasmodium-selective proteasome inhibitors
Li, H., O’Donoghue, A. J., van der Linden, W. A., Xie, S. C., Yoo, E., Foe, I. T., Tilley, L., Craik, C. S., da Fonseca, P. C. A., & Bogyo, M. (2016) · Nature · doi:10.1038/nature16936 · Cited by 238
Self-citationDihydroartemisinin–Piperaquine Failure in Cambodia
Saunders, D. L., Vanachayangkul, P., & Lon, C. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1403007 · Cited by 225
Altered temporal response of malaria parasites determines differential sensitivity to artemisinin
Klonis, N., Xie, S. C., McCaw, J. M., Crespo-Ortiz, M. P., Zaloumis, S. G., Simpson, J. A., & Tilley, L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217452110 · Cited by 213
Self-citationBakar, N. A., Klonis, N., Hanssen, E., Chan, C., & Tilley, L. (2010) · Journal of Cell Science · doi:10.1242/jcs.061499 · Cited by 204
Self-citationEgan, T. J. (2008) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2007.11.005 · Cited by 201
Carrara, V. I., Lwin, K. M., Phyo, A. P., Ashley, E., Wiladphaingern, J., Sriprawat, K., Rijken, M., Boel, M., McGready, R., Proux, S., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001398 · Cited by 185
Phyo, A. P., Jittamala, P., Nosten, F. H., Pukrittayakamee, S., Imwong, M., White, N. J., Duparc, S., Macintyre, F., Baker, M., & Möhrle, J. J. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00320-5 · Cited by 185
Leang, R., Barrette, A., Bouth, D. M., Menard, D., Abdur, R., Duong, S., & Ringwald, P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00686-12 · Cited by 185
Heme as Trigger and Target for Trioxane-Containing Antimalarial Drugs
Meunier, B., & Robert, A. (2010) · Accounts of Chemical Research · doi:10.1021/ar100070k · Cited by 183
The Keap1–Nrf2 Cell Defense Pathway – A Promising Therapeutic Target?
Copple, I. M. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-398339-8.00002-1 · Cited by 171
Hunt, P., Afonso, A., Creasey, A., Culleton, R., Sidhu, A. B. S., Logan, J., Valderramos, S. G., McNae, I., Cheesman, S., Rosario, V. D., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05753.x · Cited by 167
Self-citationKe, H., Sigala, P. A., Miura, K., Morrisey, J. M., Mather, M. W., Crowley, J. R., Henderson, J. P., Goldberg, D. E., Long, C. A., & Vaidya, A. B. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.615831 · Cited by 162
Vaid, A., Ranjan, R., Smythe, W. A., Hoppe, H. C., & Sharma, P. (2010) · Blood · doi:10.1182/blood-2009-08-238972 · Cited by 157
Huang, F. J., Takala‐Harrison, S., Jacob, C. G., Liu, H., Sun, X., Yang, H., Nyunt, M. M., Adams, M., Zhou, S., Xia, Z., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv249 · Cited by 149
Hartwig, C. L., Rosenthal, A. S., D’Angelo, J. G., Griffin, C. E., Posner, G. H., & Cooper, R. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.015 · Cited by 147
Digaleh, H., Kiaei, M., & Khodagholi, F. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1409-y · Cited by 140
Stocks, P. A., Bray, P. G., Barton, V., Al‐Helal, M., Jones, M., Araújo, N., Gibbons, P. D., Ward, S. A., Hughes, R. H., Biagini, G. A., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604697 · Cited by 140
Falcipains and Other Cysteine Proteases of Malaria Parasites
Rosenthal, P. J. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8414-2_3 · Cited by 137
Biological Actions of Artemisinin: Insights from Medicinal Chemistry Studies
Li, J., & Zhou, B. (2010) · Molecules · doi:10.3390/molecules15031378 · Cited by 137
Iron and heme metabolism in Plasmodium falciparum and the mechanism of action of artemisinins
Klonis, N., Creek, D. J., & Tilley, L. M. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.07.005 · Cited by 133
Self-citationLisewski, A. M., Quiros, J. P., Ng, C. L., Adikesavan, A. K., Miura, K., Putluri, N., Eastman, R. T., Scanfeld, D., Regenbogen, S., Altenhofen, L. M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.011 · Cited by 132
Self-citationHott, A., Casandra, D. R., Sparks, K. N., Morton, L. C., Castanares, G.-G., Rutter, A., & Kyle, D. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00197-15 · Cited by 131
Crespo, M. D. P., Avery, T. D., Hanssen, E. G., Fox, E., Robinson, T. V., Valente, P., Taylor, D. K., & Tilley, L. M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00609-07 · Cited by 130
Self-citationThe Mechanisms of Parasite Clearance after Antimalarial Treatment ofPlasmodium falciparumMalaria
Chotivanich, K., Udomsangpetch, R., Dondorp, A. M., Williams, T., Angus, B., Simpson, J. A., Pukrittayakamee, S., Looareesuwan, S., Newbold, C., & White, N. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315718 · Cited by 122
Plasmodium falciparum: multifaceted resistance to artemisinins
Paloque, L., Ramadani, A. P., Mercereau‐Puijalon, O., Augereau, J., & Benoit‐Vical, F. (2016) · Malaria Journal · doi:10.1186/s12936-016-1206-9 · Cited by 121
Talundzic, E., Okoth, S. A., Congpuong, K., Pluciński, M. M., Morton, L. C., Goldman, I. F., Kachur, S. P., Wongsrichanalai, C., Satimai, W., Barnwell, J. W., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004789 · Cited by 119
De novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite
Surolia, N., & Padmanaban, G. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91258-r · Cited by 115
Malaria's Drug Miracle in Danger
Enserink, M. (2010) · Science · doi:10.1126/science.328.5980.844 · Cited by 114
Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization
White, N. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00287-13 · Cited by 113
Möhrle, J. J., Duparc, S., Siethoff, C., van Giersbergen, P. L. M., Craft, J. C., Arbe‐Barnes, S., Charman, S. A., Gutierrez, M., Wittlin, S., & Vennerstrom, J. L. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04368.x · Cited by 107
Ouattara, A., Koné, A., Adams, M., Fofana, B., Maiga, A. W., Hampton, S., Coulibaly, D., Thera, M. A., Diallo, N., Dara, A., et al. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0605 · Cited by 105
Zhang, M., Mishra, S., Sakthivel, R., Rojas, M., Ranjan, R., Sullivan, W. J., Fontoura, B. M. A., Ménard, R., Dever, T. E., & Nussenzweig, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121567109 · Cited by 102
Antimalarial Quinolines and Artemisinin Inhibit Endocytosis in Plasmodium falciparum
Hoppe, H. C., van Schalkwyk, D. A., Wiehart, U. I. M., Meredith, S. A., Egan, J., & Weber, B. W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2370-2378.2004 · Cited by 102
Understanding artemisinin-resistant malaria
Fairhurst, R. M. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000199 · Cited by 100
Wang, Z., Shrestha, S., Li, X., Miao, J., Yuan, L., Cabrera, M., Grube, C., Yang, Z., & Cui, L. (2015) · Malaria Journal · doi:10.1186/s12936-015-0672-9 · Cited by 96
Peroxide Bond-Dependent Antiplasmodial Specificity of Artemisinin and OZ277 (RBx11160)
Kaiser, M., Wittlin, S., Nehrbass-Stuedli, A., Dong, Y., Wang, X., Hemphill, A. F., Matile, H., Brun, R., & Vennerstrom, J. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00225-07 · Cited by 95
Li, H., Ponder, E. L., Verdoes, M., Ásbjörnsdóttir, K., Deu, E., Edgington‐Mitchell, L. E., Lee, J. T., Kirk, C. J., Demo, S. D., Williamson, K. C., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.09.019 · Cited by 93
WHO Malaria Policy Advisory Committee and Secretariat (2016) · Malaria Journal · doi:10.1186/s12936-016-1169-x · Cited by 93
Tucker, M. S., Mutka, T., Sparks, K. N., Patel, J., & Kyle, D. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05540-11 · Cited by 87
Morphologic Effects of Artemisinin in Plasmodium Falciparum
Maeno, Y., Toyoshima, T., Fujioka, H., Ito, Y., Meshnick, S., Benakis, A., Milhous, W. K., & Aikawa, M. (1993) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1993.49.485 · Cited by 85
Beyond antioxidant genes in the ancient Nrf2 regulatory network
Lacher, S. E., Lee, J. S., Wang, X., Campbell, M. R., Bell, D. A., & Slattery, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.044 · Cited by 77
Na‐Bangchang, K., Ruengweerayut, R., Mahamad, P., Ruengweerayut, K., & Chai่jaroenkul, W. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-273 · Cited by 77
Muwanguzi, J. K., Henriques, G., Sawa, P., Bousema, T., Sutherland, C. J., & Beshir, K. B. (2016) · Malaria Journal · doi:10.1186/s12936-016-1095-y · Cited by 74
Yang, T., Xie, S. C., Cao, P., Giannangelo, C., McCaw, J. M., Creek, D. J., Charman, S. A., Klonis, N., & Tilley, L. M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-16 · Cited by 72
Self-citationWHO Malaria Policy Advisory Committee and Secretariat (2015) · Malaria Journal · doi:10.1186/s12936-015-0623-5 · Cited by 72
Haynes, R. K., Cheu, K., Chan, H., Wong, H. N., Li, K., Tang, M. M., Chen, M., Guo, Z., Guo, Z., Sinniah, K., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200383 · Cited by 71
Cooper, R. A., Conrad, M. D., Watson, Q. D., Huezo, S. J., Ninsiima, H., Tumwebaze, P. K., Nsobya, S. L., & Rosenthal, P. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00921-15 · Cited by 68
Henriques, G., Martinelli, A., Rodrigues, L., Modrzynska, K., Fawcett, R., Houston, D. R., Borges, S. T., D’Alessandro, U., Tinto, H., Karema, C., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-118 · Cited by 64
Ndour, P. A., Lopera-Mesa, T. M., Diakité, S. A. S., Chiang, S., Mouri, O., Roussel, C., Jauréguiberry, S., Biligui, S., Kendjo, É., Claessens, A., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu427 · Cited by 64
Li, H., Tsu, C. A., Blackburn, C., Li, G., Hales, P., Dick, L. R., & Bogyo, M. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja507692y · Cited by 64
Petersen, I., Gabryszewski, S. J., Johnston, G. L., Dhingra, S. K., Ecker, A., Lewis, R. E., de Almeida, M. J., Straimer, J., Henrich, P. P., Palatulan, E. L., et al. (2015) · Molecular Microbiology · doi:10.1111/mmi.13035 · Cited by 50
Self-citationClark, M. A., Fisher, N. C., Kasthuri, R. S., & Hand, C. C. (2013) · British Journal of Haematology · doi:10.1111/bjh.12234 · Cited by 48
Ding, X., Luo, C., Ren, K., Zhang, J., Zhou, J., Hu, X., Liu, R., Wang, Y., Gao, X., & Zhang, J. (2008) · DNA and Cell Biology · doi:10.1089/dna.2007.0662 · Cited by 38
Tschan, S., Brouwer, A. J., Werkhoven, P. R., Jonker, A. M., Wagner, L., Knittel, S., Aminake, M. N., Pradel, G., Joanny, F., Liskamp, R. M. J., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00742-12 · Cited by 35
Akompong, T., VanWye, J., Ghori, N., & Haldar, K. (1999) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(99)00056-0 · Cited by 29
Bioinformatics analyses provide insight into distant homology of the Keap1–Nrf2 pathway
Gaćeša, R., Dunlap, W. C., & Long, P. F. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.015 · Cited by 24
Saha, N., Möhrle, J. J., Zutshi, A., et al. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.232 · Cited by 18
Cited by
Phillips, M. A., Burrows, J. N., Manyando, C., van Huijsduijnen, R. H., Van Voorhis, W. C., & Wells, T. N. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.50 · Cited by 649
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
Blasco, B., Leroy, D., & Fidock, D. A. (2017) · Nature Medicine · doi:10.1038/nm.4381 · Cited by 576
Self-citationThe past, present and future of anti-malarial medicines
Tse, E. G., Korsik, M., & Todd, M. H. (2019) · Malaria Journal · doi:10.1186/s12936-019-2724-z · Cited by 471
A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites
Birnbaum, J., Scharf, S., Schmidt, S., Jonscher, E., Hoeijmakers, W. A. M., Flemming, S., Toenhake, C. G., Schmitt, M., Sabitzki, R., Bergmann, B., et al. (2020) · Science · doi:10.1126/science.aax4735 · Cited by 419
WWARN K13 Genotype-Phenotype Study Group (2019) · BMC Medicine · doi:10.1186/s12916-018-1207-3 · Cited by 320
Metadata
- Authors
- Tilley, L., Straimer, J., Gnädig, N. F., Ralph, S. A., & Fidock, D. A.
- Venue
- Trends in Parasitology
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 32
- Issue
- 9
- Pages
- 682-696
- ISSN
- 1471-4922 (ISSN-L)
- OpenAlex
- W2415187468
- Cited by
- 359
- References
- 120
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.